According to a law firm press release, this action stems from a proposed transaction announced on June 15, 2016, pursuant to which Envision Healthcare will be acquired by AmSurg Corp. (“Parent”) through Parent’s wholly-owned subsidiary, New Amethyst Corp. (“Merger Sub,” and together with Parent, “AmSurg”). On June 15, 2016, the Board caused Envision to enter into an agreement and plan of merger (the “Merger Agreement”). Pursuant to the terms of the Merger Agreement, AmSurg will acquire all of the outstanding shares of Envision common stock for 0.334 AmSurg shares per Envision share, in a transaction valued at approximately $4.73 billion. The Complaint alleges that the Form S-4 Registration Statement omits material information with respect to the proposed transaction, which renders the Form S-4 Registration Statement false and misleading.

This case was voluntarily dismissed on January 6, 2017.